| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |